本产品仅可用于科研实验,严禁用于其他非科研用途!抗体名称 Anti-MESP1 Antibody 指标别名 mesoderm posterior bHLH transcription factor 1;bHLHc5;MESP1 克隆性 Polyclonal 检验物种 human 应用范围 WB,ELISA 基因名称 MESP1 抗体来源 Rabbit 抗体类型 IgG 免疫原 E.coli-derived human MESP1 recombinant protein (...
Invitrogen Anti-MESP1 Polyclonal, Catalog # PA5-49441. Tested in Western Blot (WB) applications. This antibody reacts with Mouse samples. Supplied as 400 µL purified antibody (Lot-Specific).
Mesp1 Antibody (939826) [Janelia Fluor® 549], Novus Biologicals Bio-Techne includes Novus Biologicals | Catalog # FAB92193I Submit a review Product Datasheet / COA / SDS Catalog # Availability Size / Price Qty Loading... FAB92193I Add To Cart Print Quote Bulk Order View ...
View Human MESP1 Antibody (MAB92193) validated in Human. Additional non-catalog clones available.
英文名字 Mouse Mesp1 Antibody (Center) 供应商 Abgent 产品货号 A-AP16455c 产品报价 ￥2310/400 ul 产品说明书 点击查看 购买方式 产品新闻 背景资料 应用类型 WB,ELISA 免疫原 Mouse Mesp1 来源宿主 反应性 保存建议 2-8 其他 ABGENT 注意 该页面的中文产品信息的翻译,仅供参考。准确的产品信息请以厂家的...
Mouse Monoclonal MESP1 Antibody (1A3) Mouse Monoclonal MESP1 Antibody (1A3) 价格电议 起批量≥1 ml 最小起订电询 供货总量电询 发货地址上海市杨浦区 建议售价￥电议/ml 更新日期2024年10月22日 产品规格见优宁维官网 洽谈立即询价查看联系方式
中文名称: Mesp1 中文同义词: 英文名称: Mesp1 英文同义词: Anti-IR1899308;Anti-mesoderm posterior 1 homolog (mouse);Anti-MGC10676;bHLHc5;MGC10676;Monoclonal Anti-MESP1 antibody produced in mouse;Anti-MESP1, (N-terminal) antibody produced in rabbit;ANTI-MOUSE MESP1 (CENTER) antibody produced ...
CAS号: 英文名: MESP1 antibody (Biotin) 英文别名: MESP1 antibody (Biotin) 中文名: 中文别名: CBNumber: CB86006028 分子式: 分子量: 0 MOL File: Mol file 化学性质 安全信息 用途 供应商 1 MESP1 antibody (Biotin)化学性质安全信息 ...
Isotype controls (BD Biosciences cat no: 557714 (isotype for CD31) and 562292 (isotype for CD34)) were used at the same concentration as their respective primary antibody. Slides were mounted with mounting medium (Vectorshield, Vector Lab, UK) containing DAPI for staining of nuclei, and images...
Fas decoy, TSP1 receptor antibody and Pifithrin, a p53 inhibitor, severely decreased apoptosis and restored angiogenesis by DXR鈥揇I-TSP combination, evidencing critical roles of CD95 and TSP1. Combined therapy synergistically blocked neovascularization and progression of the bladder and prostate ...